葵花药业：子公司复方聚乙二醇（3350）电解质散获得药品注册证书

Core Viewpoint - The company announced that its subsidiary, Kewang Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the registration of a new drug, Compound Polyethylene Glycol (3350) Electrolyte Powder [1] Group 1 - The newly approved drug's main ingredients include polyethylene glycol 3350, sodium chloride, potassium chloride, and sodium bicarbonate [1] - The drug is classified as a Class 3 chemical drug and is categorized as a prescription medication [1] - The product specification is 6.9g per bag [1]